Arsenic trioxide with ascorbic acid and high-dose melphalan: A new preparative regimen for autologous hematopoietic stem cell transplantation for multiple myeloma.

被引：0
|
作者：
Qazilbash, MH [1 ]
Davis, MS [1 ]
Ana, A [1 ]
Roden, L [1 ]
Libunao, F [1 ]
Tball, PF [1 ]
Wang, XM [1 ]
Couriel, D [1 ]
De Lima, M [1 ]
Hosing, C [1 ]
Kebriaei, P [1 ]
Weber, D [1 ]
Wang, M [1 ]
Jones, RB [1 ]
Matthes, SG [1 ]
Champlin, RE [1 ]
Giralt, SA [1 ]
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1159
引用
收藏
页码：338A / 339A
页数：2
相关论文
共 50 条
  • [31] High-dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative regimens for autologous stem cell transplantation in patients with multiple myeloma
    Benson, Don M., Jr.
    Elder, Patrick J.
    Lin, Thomas S.
    Blum, William
    Penza, Sam
    Avalos, Belinda
    Copelan, Edward
    Farag, Sherif S.
    LEUKEMIA RESEARCH, 2007, 31 (08) : 1069 - 1075
  • [32] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Alexandra Gomez-Arteaga
    Tomer M. Mark
    Danielle Guarneri
    Paul J. Christos
    Usama Gergis
    June D. Greenberg
    Jingmei Hsu
    Sebastian A. Mayer
    Ruben Niesvizky
    Roger N. Pearse
    Adrienne A. Phillips
    Adriana Rossi
    Morton Coleman
    Koen van Besien
    Tsiporah B. Shore
    Bone Marrow Transplantation, 2019, 54 : 2027 - 2038
  • [33] High-dose bendamustine and melphalan conditioning for autologous stem cell transplantation for patients with multiple myeloma
    Gomez-Arteaga, Alexandra
    Mark, Tomer M.
    Guarneri, Danielle
    Christos, Paul J.
    Gergis, Usama
    Greenberg, June D.
    Hsu, Jingmei
    Mayer, Sebastian A.
    Niesvizky, Ruben
    Pearse, Roger N.
    Phillips, Adrienne A.
    Rossi, Adriana
    Coleman, Morton
    van Besien, Koen
    Shore, Tsiporah B.
    BONE MARROW TRANSPLANTATION, 2019, 54 (12) : 2027 - 2038
  • [34] A Randomized Phase II Trial of High-Dose Melphalan, Ascorbic Acid and Arsenic Trioxide with or without Bortezomib in Multiple Myeloma
    Sharma, Manish
    Thall, Peter
    Wang, Xuemei
    Hosing, Chitra
    Mendoza, Floralyn L.
    Han, Eric
    Wang, Michael
    Weber, Donna
    Shah, Jatin
    Alousi, Amin
    Anderlini, Paolo
    Kebriaei, Partow
    Khouri, Issa F.
    Popat, Uday
    de Lima, Marcos
    Champlin, Richard E.
    Giralt, Sergio
    Qazilbash, Muzaffar
    BLOOD, 2009, 114 (22) : 912 - 912
  • [35] Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen
    Hagen, Patrick
    D'Souza, Anita
    Hari, Parameswaran
    Davila, Omar
    Zhang, Mei-Jie
    Vesole, David H.
    Smith, Scott E.
    Rodriguez, Tulio E.
    Stiff, Patrick J.
    LEUKEMIA & LYMPHOMA, 2020, 61 (14) : 3484 - 3492
  • [36] High-dose chemotherapy with autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Gertz, Marie A.
    Lacy, Martha Q.
    Dispenzieri, Angela
    Hayman, Suzanne R.
    Kumar, Shaji K.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2006, 6 (03) : 343 - 360
  • [37] High-dose chemotherapy with autologous stem cell rescue in multiple myeloma.
    Mahendra, P
    Ethell, M
    Johnson, D
    Seale, J
    Bass, G
    Marcus, RE
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 297 - 297
  • [38] Mitoxantrone and melphalan as conditioning regimen for autologous stem cell transplant for multiple myeloma.
    Beaven, Anne W.
    Comeau, Terrance
    Sharf, Andrew
    Moore, Dominic T.
    Serody, Jonathan
    Shea, Thomas C.
    Gabriel, Don A.
    BLOOD, 2006, 108 (11) : 834A - 834A
  • [39] The effectiveness of the conditioning regimen high dose melphalan with bortezomib with autologous transplantation of hematopoietic stem cells in patients with multiple myeloma
    Khorobrykh, Marina
    Zorina, Natalia
    Minaeva, Natalia
    Sherstnev, Philipp
    Paramonov, Igor
    BONE MARROW TRANSPLANTATION, 2018, 53 : 293 - 294
  • [40] Cardiac toxicity of high-dose cyclophosphamide and melphalan in patients with multiple myeloma treated with tandem autologous hematopoietic stem cell transplantation
    Samo Zver
    Vesna Zadnik
    Peter Černelč
    Mirta Koželj
    International Journal of Hematology, 2008, 88 : 227 - 236
12345